Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Creative Enzymes Expands Its Service Offering with the Launch of Custom Enzyme Blends

    Nov 29, 2022, 09:32 AM by
    Full story
  • Creative Enzymes Provides DNA Molecular Weight Markers and Ladders

    Nov 29, 2022, 09:32 AM by
    Full story
  • CD Genomics Expands Its Sequencing Portfolio with the Launch of Whole Exome Sequencing

    Nov 29, 2022, 09:31 AM by
    Full story
  • MicrobioSeq Boosts Scientific Research with Gene Expression Analysis

    Nov 29, 2022, 09:31 AM by
    Full story
  • Follow the Money: Quantum Computer-Based AI for Drug Discovery, Insilico Medicine’s Multidisciplinary Drug Discovery Platform, More

    Nov 29, 2022, 01:00 AM by User Not Found
    Bio-IT World | Funding for first-in-class peptide-drug conjugate for tumor cells, gene delivery research and development, next-generation orthopedic products, and more.
    Full story
  • Vaxess Adds Fenel Eloi to Board of Directors

    Nov 28, 2022, 15:39 PM by
    Eloi brings more than 30 years of life science leadership experience to Vaxess’ board; will advise company as it moves towards commercialization of MIMIX vaccine patch
    Full story
  • Micro-Sphere Launches New Research & Development Services at Swiss Site

    Nov 28, 2022, 15:39 PM by
    Global contract development and manufacturing organisation (CDMO) Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation.
    Full story
  • Flywheel Building Federated Data Platform for Development of Unbiased Breast Imaging AI

    Nov 28, 2022, 15:38 PM by
    Flywheel is creating a federated data network aimed at improving AI for breast imaging—on a scale not previously possible.
    Full story
  • Zebrafish Disease Model: Developed by Creative Biogene to Support Multiple Therapeutic Areas

    Nov 28, 2022, 15:38 PM by
    Full story
  • IntegrateRNA Develops Premade Circular RNA Products to Satisfy Various Downstream Applications

    Nov 28, 2022, 15:37 PM by
    Full story
  • Microbiosci Develops Data-independent Acquisition Proteomics to Support Molecular Diagnostics

    Nov 28, 2022, 15:37 PM by
    Full story
  • Creative Bioarray Develops More Than 1000 Cell Types Together with Selective Cell Culture Media

    Nov 28, 2022, 15:36 PM by
    Full story
  • Creative Bioarray Releases GMP Grade Cytokines to Support Cell Manufacturing and Cell-based Therapies

    Nov 28, 2022, 15:35 PM by
    Full story
  • Acroscell Develops CiPA in Silico Modeling to Identify and Optimize Drug Candidates

    Nov 28, 2022, 15:34 PM by
    Full story
  • FDA Approved ADC Drugs list up to 2022

    Nov 28, 2022, 15:33 PM by
    Antibody-drug conjugates(ADCs) are use specific linkers to connect antibodies and small molecule cytotoxic drugs, and their main components include antibodies, linkers and small molecular cytotoxic drugs.
    Full story
  • Alfa Chemistry Strengthens Its Analytical Testing Business with A Diversified Product & Service Portfolio

    Nov 28, 2022, 15:32 PM by
    Analytical testing plays a pivotal role in nearly all fields and industries for quality and safety assurance. Fairly recently, the management team of Alfa Chemistry announced to further diversify its product & service portfolios, aiming to provide testing services as effectively and efficiently as possible to maximize customers' profits.
    Full story
  • Embracing Innovation–BOC Sciences Strengthens the Production of Cosmetics Ingredients

    Nov 28, 2022, 15:32 PM by
    It's verified by BOC Sciences officials that the critical specialty chemical distearyl phthalic acid amide is now in steady supply, aiming to accelerate the development of cosmetics industry.
    Full story
  • Insecticides and Metabolite Standards

    Nov 28, 2022, 15:27 PM by
    Full story
  • Polymer Characterization -- BOC Sciences

    Nov 28, 2022, 15:26 PM by
    Full story
  • NCC Group Monthly Threat Pulse – October 2022 - Ransomware attacks decrease but DDoS attacks on the rise

    Nov 28, 2022, 15:25 PM by
    Analysis from NCC Group’s Global Threat Intelligence team has revealed a decrease in ransomware attacks in October. However, there has been a notable shift in tactics, with more prevalent use of distributed denial of service (DDoS). In fact, October saw the highest number of DDoS incidents recorded this year.
    Full story
  • «
  • 111
  • 112
  • 113 (current)
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy